A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-26
SponsorTulane University

About this trial

This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Identifies as African American or Black

15-26 years of age

Lives or spends most of their time in Orleans Parish

Had vaginal sex at least once

Disqualifiers

Unwilling or unable to provide informed consent

Unable to speak or understand English

Previously enrolled in the study

Trial design

Design model

Single group

Treatments tested in this trial

  • Chlamydia, gonorrhea, syphilis, and HIV screening

    Other intervention

    Individuals aged 15-26 years old will be tested for chlamydia, gonorrhea, HIV, and syphilis at community based venues. Individuals who test positive for chlamydia and gonorrhea and their sexual partners will be offered expedited treatment at participating pharmacies. Individuals who test positive will be asked to be rescreened for Ct/GC at 3 months post treatment.

Treatment groups

2,322 Participants
are divided into 1 treatment group
Group A: Chlamydia, gonorrhea, syphilis, and HIV screeningExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Rate of chlamydia in women

Primary outcome

Time frame
up to 60 months

Secondary outcomes

1

Index participant medication pickup rate

Percentage of index participants who obtain their prescribed medication from a partnering pharmacy among all index participants who report intending to pick up the medication. Medication receipt will be determined from pharmacy billing records. Rates will be calculated monthly.

Time frame
up to 60 months
2

Partner medication pickup rate

Percentage of partners who obtain their prescribed medication from a partnering pharmacy among all partners reported as intending to pick up the medication. Medication receipt will be determined from pharmacy billing records. Rates will be calculated monthly.

Time frame
60 months
3

Self reported treatment of index participants and partners

Number and percentage of index participants who report that they and all applicable partner(s) received treatment. The denominator will include index participants who provide follow-up information about their own and their partner(s)' treatment status.

Time frame
60 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tulane University

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator